Effects of phentolamine on tissue perfusion in pediatric cardiac surgery

O Köner1, S Tekin, A Köner

  • 1Department of Anaesthesiology and Intensive Care, Cardiology Institute of Istanbul University, Turkey.

Insights

Phentolamine administration during cardiopulmonary bypass (CPB) in pediatric heart surgery reduced lactate levels and improved body perfusion. This suggests phentolamine can mitigate CPB

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Pharmacology

Background:

  • Cardiopulmonary bypass (CPB) can cause adverse effects in pediatric patients with congenital heart disease.
  • Pharmacologic vasodilation may offer a strategy to mitigate these effects.

Purpose of the Study:

  • To assess if phentolamine-induced vasodilation can counteract the detrimental effects of CPB in pediatric patients undergoing cardiac surgery.
  • To evaluate the impact of phentolamine on metabolic and perfusion parameters during and after CPB.

Main Methods:

  • Prospective, randomized clinical study involving 43 pediatric patients with congenital heart disease.
  • Patients received either phentolamine during CPB (Group 1, n=22) or no phentolamine (Group 2, n=21).
  • Measurements included temperature gradients and serum lactate levels before, during, and after CPB; systemic oxygen consumption was also assessed.

Main Results:

  • Phentolamine group showed significantly lower lactate levels post-CPB and at operation end (p < 0.05).
  • Improved central-peripheral temperature uniformity was observed in the phentolamine group during and after CPB (p < 0.05).
  • Systemic oxygen consumption was higher in the phentolamine group post-rewarming (p < 0.05), though mean arterial pressure was lower post-CPB (p = 0.03).

Conclusions:

  • Phentolamine administration during CPB in pediatric cardiac surgery is associated with reduced anaerobic metabolism.
  • Phentolamine appears to promote more uniform body perfusion in this patient population.
  • The findings suggest phentolamine is a potential adjunct for managing CPB-related complications in pediatric congenital heart disease surgery.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...